METASTATIC CANCER
Clinical trials for METASTATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CANCER trials appear
Sign up with your email to follow new studies for METASTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered NK cells take on tough cancers in first human test
Disease control Not yet recruitingThis early-phase trial tests a new type of immune cell therapy for people with advanced solid tumors that have not responded to standard treatments. The therapy uses a patient's own natural killer (NK) cells that have been genetically modified to produce IL-15, a protein that hel…
Matched conditions: METASTATIC CANCER
Phase: EARLY_PHASE1 • Sponsor: Genovn Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New radiation method aims to shrink large tumors better
Disease control Not yet recruitingThis phase 2 trial compares a new type of radiation called LATTICE radiotherapy with standard palliative radiation for people who have large metastatic tumors (over 2.5 cm). The LATTICE method delivers a very high dose to the center of the tumor while keeping lower doses to the s…
Matched conditions: METASTATIC CANCER
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for kidney cancer patients with bone spread: drug combo trial launches
Disease control Not yet recruitingThis phase 2 trial tests a new drug called zanzalintinib, taken as a pill, combined with a bone-strengthening agent for people with advanced kidney cancer that has spread to the bones. The study enrolls 20 participants whose cancer has worsened after 1–3 prior treatments, includi…
Matched conditions: METASTATIC CANCER
Phase: PHASE2 • Sponsor: Kelly Fitzgerald, MD • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Personalized cancer treatment: matching drugs to tumor DNA may delay disease worsening
Disease control Not yet recruitingThis study tests whether drugs chosen to match specific DNA mutations in a patient's tumor can delay cancer worsening better than standard treatments. About 280 adults with metastatic or unresectable solid cancers will be randomly assigned to receive either DNA-matched therapy or…
Matched conditions: METASTATIC CANCER
Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New study tests if tiny probes can slash cancer pain without heavy drugs
Symptom relief Not yet recruitingThis study looks at whether interventional radiology—a minimally invasive technique using needles or probes—can reduce pain and improve daily life for people with advanced or metastatic cancer. About 125 adults whose cancer has spread and who are expected to live at least 3 month…
Matched conditions: METASTATIC CANCER
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Chef-Approved diet may help cancer patients keep muscle and strength
Symptom relief Not yet recruitingThis study tests whether personalized cooking and food guidance can help slow muscle loss in people with advanced cancer who are on chemotherapy. About 200 adults will be split into two groups: one gets standard nutrition care plus exercise advice, and the other gets the same plu…
Matched conditions: METASTATIC CANCER
Phase: NA • Sponsor: Gali Perel • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC